Table 1. Pre-operative characteristics of BPD-DS surgery women.
| Variables | Non-diabetic | Diabetic | |
|---|---|---|---|
| Demographics and treatment | 32 | 22 | P |
| Age (years) | 38.3±10.3 | 42.0±10.6 | NS |
| Diabetic medication (%) | 0/32 (0%) | 20/22 (91%) | <0.001 |
| Lipid medication | 4/32 (13%) | 18/22 (82%) | <0.001 |
| Body composition | |||
| BMI (kg m−2) | 48.6±7.4 | 49.8±7.9 | NS |
| Fat mass (kg) | 66.9±13.5 | 66.2±14.8 | NS |
| Lean mass (kg) | 59.3±8.1 | 61.0±9.5 | NS |
| Fat percentage (%) | 52.8±2.6 | 51.7±3.6 | NS |
| Biochemical measures | |||
| ASP (nmol l−1) | 30.0±15.7 | 38.4±21.0 | <0.05 |
| C3 (mg dl−1) | 1.99±0.34 | 2.09±0.4 | NS |
| hsCRP (mg dl−1) | 14.1±24.2 | 10.8±8.1 | NS |
| Glucose (mmol dl−1) | 5.76±1.67 | 8.28±3.28 | <0.001 |
| HbA1c (%) | 5.62±0.88 | 6.81±1.03 | <0.001 |
| Insulin (pmol l−1) | 149±71 | 193±119 | |
| Fructosamine (μmol l−1) | 202±33 | 230±47 | <0.01 |
| Lipid parameters | |||
| TG (mmol l−1) | 1.38±0.57 | 1.81±0.82 | <0.05 |
| Cholesterol (mmol l−1) | 4.80±0.68 | 4.53±1.04 | NS |
| HDL-Chol (mmol l−1) | 1.40±0.30 | 1.26±0.35 | NS |
| LDL-Chol (mmol l−1) | 2.78±0.59 | 2.45±0.77 | NS |
| Apo-B (mmol l−1) | 0.79±0.16 | 0.75±0.20 | NS |
| NEFA (mmol l−1) | 0.55±0.12 | 0.53±0.17 | NS |
Abbreviations: ASP acylation stimulating protein; BMI, body mass index; Chol, cholesterol; hsCRP, high-sensitivity C-reactive protein; NEFA, non-esterified fatty acid; TG, triglyceride; The values are presented as mean±s.d. and significant differences analyzed by Student's t-test for non-diabetic women vs diabetic women where pNS indicates not significant. For diabetic and lipid lowering medication, results were analyzed by χ2.